NCT05709626View on ClinicalTrials.gov

PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,258

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

January 4, 2025

Study Completion Date

January 4, 2028

Conditions
ST-segment Elevation Myocardial Infarction (STEMI)
Interventions
DRUG

No aspirin (Prasugurel monotherapy)

12-month prasugrel monotherapy

DRUG

12-month DAPT

12-month dual antiplatelet therapy with prasugrel and aspirin

Trial Locations (1)

589-8511

RECRUITING

Kindai University Faculty of Medicine, Sayama

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Kindai University

OTHER